Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial

NCT04308668 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04308668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04308668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Completed
Start date
March 17, 2020
Completion date
May 20, 2020
Enrollment
1,312 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, corona virus infection, coronavirus, coronavirus infections, sars-cov infection